Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Studies on the shift of cefmetazole into the gastrointestinal tract (author's transl)].

Minamitani M, Hayashi H, Tohma T, Kojima T, Sahashi Y, Terao T.

Jpn J Antibiot. 1980 Jan;33(1):10-7. Japanese.

PMID:
6929355
2.
3.

[Profile of cefmetazole. II. Absorption, excretion, distribution and metabolism (author's transl)].

Kawada Y.

Kansenshogaku Zasshi. 1979 Feb;53(2):66-74. Japanese. No abstract available.

PMID:
115937
4.

Pharmacokinetics of the new cephalosporins.

Brogard JM, Comte F.

Antibiot Chemother (1971). 1982;31:145-210. Review. No abstract available.

PMID:
6277241
6.

[Treatment of E. coli meningitis with cefmetazole. Report of two cases with favorable response and determination of the concentrations in CSF (author's transl)].

Kobayashi Y, Morikawa Y, Haruta T, Fujiwara T, Kuroki S.

Jpn J Antibiot. 1979 May;32(5):598-605. Japanese.

PMID:
379388
7.

[Examination of blood levels and urinary excretion of cefmetazole in the mature and immature neonates (author's transl)].

Nanri S, Sunakawa K, Yamashita N, Akita H, Hotta M, Ichihashi Y, Ishikawa K, Okazaki K, Kanemitsu T, Ri S.

Jpn J Antibiot. 1981 Jun;34(6):874-9. Japanese.

PMID:
6945447
8.

Enhanced small intestinal absorption of cefmetazole and cefoxitin in rats in the presence of non-surfactant adjuvants.

Nishihata T, Takahagi H, Higuchi T.

J Pharm Pharmacol. 1983 Feb;35(2):124-5. No abstract available.

PMID:
6131983
9.

Absorption, distribution, excretion and metabolism of cefmetazole in cynomolgus monkeys.

Shindo H, Kawai K, Ikeda T, Igarashi I, Sugawara S.

J Antibiot (Tokyo). 1982 Jun;35(6):742-54.

10.

[Experimental and clinical studies on 6059-S (author's transl)].

Toyonaga Y, Sugita M, Kurosu Y, Kumagai K, Hori M, Takahashi T.

Jpn J Antibiot. 1981 May;34(5):764-81. Japanese.

PMID:
6457175
11.
12.

Effect of salicylate on the rectal absorption of lidocaine, levodopa, and cefmetazole in rats.

Nishihata T, Rytting JH, Higuchi T.

J Pharm Sci. 1982 Aug;71(8):869-72.

PMID:
6956717
13.

[Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].

Motohiro T, Sakata Y, Fujimoto T, Nishiyama T, Ishimoto K, Tominaga K, Yamashita F, Onoda Y, Kusayanagi T, Tsuboi M, Toubo Y, Yamamoto M, Komatsu R, Tanaka C, Baba Y.

Jpn J Antibiot. 1982 Mar;35(3):821-34. Japanese.

PMID:
6954289
14.

[Cefmetazole in the treatment of bacterial infections in the newborn (author's transl)].

Kobayashi Y, Haruta T, Morikawa Y, Kuroki S, Okura K, Fujiwara T.

Jpn J Antibiot. 1980 Nov;33(11):1237-46. Japanese.

PMID:
6941035
15.

Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.

Minami S, Araki H, Watanabe Y, Yasuda T, Takai A, Saikawa I, Mitsuhashi S.

Antimicrob Agents Chemother. 1986 Feb;29(2):376-8.

16.

[A study on cefmetazole in the neonatal period (author's transl)].

Iwai N, Sasaki A, Taneda Y, Inokuma K.

Jpn J Antibiot. 1981 Jun;34(6):881-92. Japanese.

PMID:
6945448
17.

[A study of clinical application of cefmetazole in perinatal period (author's transl)].

Cho N, Fukunaga K, Kunii K.

Jpn J Antibiot. 1981 Jun;34(6):915-24. Japanese.

PMID:
6945452
18.

Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animals.

Komiya M, Kikuchi Y, Tachibana A, Yano K.

Antimicrob Agents Chemother. 1981 Aug;20(2):176-83.

19.

[Basic study on efficacy of cefmetazole against osseous and articular infections (author's transl)].

Kawashima M, Tamura H, Kitahara Y, Jinyama K.

Jpn J Antibiot. 1982 Mar;35(3):835-9. Japanese.

PMID:
6954290
20.

Supplemental Content

Support Center